We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Interleukin 18 and IL-18 BP response to Sars-CoV-2 virus infection.
- Authors
Marino, Luca; Criniti, Anna; Guida, Sofia; Bucci, Tommaso; Ballesio, Laura; Suppa, Marianna; Galardo, Gioacchino; Vacca, Alessandra; Santulli, Maria; Angeloni, Antonio; Lubrano, Carla; Gandini, Orietta
- Abstract
The immune response to the SARS-CoV-2 infection is crucial to the patient outcome. IL-18 is involved in the lymphocyte response to the disease and it is well established its important role in the complex developing of the host response to viral infection. This study aims at the analysis of the concentrations of IL-18, IL-18BP, INF-γ at the onset of the SARS-CoV-2 infection. The serum levels of measured interleukins were obtained through enzyme-linked immunosorbent assay. Furthermore, the free fraction of IL-18 was numerically evaluated. The enrolled patients were divided in two severity groups according to a threshold value of 300 for the ratio of arterial partial pressure of oxygen and fraction of inspired oxygen fraction and according to the parenchymal involvement as evaluated by computerized tomography at the admittance. In the group of patients with a more severe disease, a significant increase of the IL-18, INF-γ and IL-18BP levels have been observed, whereas the free IL-18 component values were almost constant. The results confirm that, at the onset of the disease, the host response keep the inflammatory cytokines in an equilibrium and support the hypothesis to adopt the IL-18BP modulation as a possible and effective therapeutic approach.
- Subjects
VIRUS diseases; SARS-CoV-2; ENZYME-linked immunosorbent assay; COMPUTED tomography; THERAPEUTICS
- Publication
Clinical & Experimental Medicine, 2023, Vol 23, Issue 4, p1243
- ISSN
1591-8890
- Publication type
Article
- DOI
10.1007/s10238-022-00943-9